Ambry Genetics

Ambry Genetics is a genetic testing company that helps patients and healthcare providers make informed decisions about health and care. For more than 25 years, it has developed accessible testing solutions, with offerings spanning hereditary cancer, cardiology, neurology, clinical genomics, and rare diseases. Its services also include exome testing, postmortem testing, and RNA analysis to help clarify certain genetic variants.

Ambry supports people and clinicians throughout the testing process with ordering guidance, sample kits, forms, educational materials, and billing and insurance information. Its digital health tools include the CARE Program, which helps providers identify patients at elevated risk or potentially eligible for genetic testing. The Patient for Life program reanalyzes results as scientific understanding of gene-disease relationships develops, while Ambry Classifi and +RNAinsight provide additional tools for interpreting genetic findings. The company also offers pharmaceutical services and works with research and industry partners to advance genetics. Ambry emphasizes scientific rigor and collaboration, providing resources, educational programs, and ongoing support to help translate genetic insights into meaningful clinical decisions.